Business
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Cryptocurrency
Blockchain
Markets
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
Politics
US
World
White House
Elections
General News
Forex
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment
Top Stories
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Business
Corp. News
Latest Headlines
Biotech
Investors
Stock Alerts
IPOs
M&A
Top Stories
Breaking News
Earnings
Canadian
UK
Wallstreet Events
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Crypto
Cryptocurrency
Blockchain
Markets
Market News
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
US
World
White House
Elections
General News
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health News
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment News
Top Stories
Music News
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium
Intelligent Investor
Biotech Investor
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Downgrades
Updated: Tuesday, June 9, 2026 8:43:23 AM
Date
Broker
Company
Symbol
To
From
Target
2/7/25
William Blair
Sprinklr, Inc.
CXM
Market Perform
Outperform
N/A
2/7/25
William Blair
Sprinklr, Inc.
CXM
Market Perform
Outperform
N/A
2/7/25
Wedbush
SolarWinds, Inc.
SWI
Neutral
Outperform
$18.50 Down From $20
1/30/25
William Blair
CARGO Therapeutics, Inc.
CRGX
Market Perform
Outperform
N/A
1/29/25
William Blair
Paragon 28, Inc.
FNA
Market Perform
Outperform
N/A
1/17/25
Wedbush
Keros Therapeutics, Inc.
KROS
Neutral
Outperform
$15 Down From $47
1/10/25
Wedbush
IGM Biosciences Inc
IGMS
Neutral
Outperform
$3 Down From $22
1/7/25
William Blair
Inari Medical, Inc.
NARI
Market Perform
Outperform
N/A
1/6/25
Wedbush
Wayfair
W
Neutral
Outperform
$44 Down From $45
1/2/25
William Blair
Hillman Solutions Corp.
HLMN
Market Perform
Outperform
N/A
12/11/24
William Blair
Dave & Buster's Entertainment, Inc.
PLAY
Market Perform
Outperform
N/A
12/3/24
Wedbush
Cavco Industries Inc
CVCO
Neutral
Outperform
$480
11/21/24
William Blair
Pyxis Oncology, Inc.
PYXS
Market Perform
Outperform
N/A
11/1/24
Wedbush
Cinemark Holdings Inc.
CNK
Neutral
Outperform
$32
10/30/24
Wedbush
Williams-Sonoma Inc.
WSM
Neutral
Outperform
$135 Down From $150
9/24/24
Wedbush
First Horizon Corporation
FHN
Neutral
Outperform
$17 Down From $20
9/24/24
Wedbush
First Citizens Bancshares Inc.
FCNCA
Neutral
Outperform
$2150 Down From $2450
9/24/24
Wedbush
Customers Bancorp, Inc.
CUBI
Neutral
Outperform
$53 Down From $79
9/4/24
Wedbush
Purple Communications, Inc.
PRPL.
Neutral
Outperform
$1.10 Down From $1.75
9/4/24
Wedbush
Somnigroup International Inc.
SGIC
Neutral
Outperform
$52
8/7/24
Wedbush
G1 Therapeutics, Inc.
GTHX
Neutral
Outperform
$7.15 Up From $3.00
7/1/24
William Blair
Amedisys
AMED
Market Perform
Outperform
N/A
6/18/24
Wedbush
Zentalis Pharmaceuticals, LLC
ZNTL
Underperform
Neutral
$4 Down From $15
6/11/24
Wedbush
CoreCivic Inc
CXW
Neutral
Outperform
$14 Down From $19
5/30/24
William Blair
UiPath Inc.
PATH
Market Perform
Outperform
N/A
5/10/24
William Blair
Ginkgo Bioworks Holdings, Inc.
DNA
Underperform
Marketperform
N/A
5/6/24
William Blair
Perficient Inc.
PRFT
Market Perform
Outperform
N/A
5/3/24
William Blair
Sprout Social, Inc.
SPT
Market Perform
Outperform
N/A
5/2/24
William Blair
Wolfspeed, Inc.
WOLF
Market Perform
Outperform
N/A
5/1/24
William Blair
CVRx, Inc.
CVRX
Market Perform
Outperform
N/A
4/11/24
Wedbush
Walker & Dunlop, Inc.
WD
Neutral
Outperform
$95 Down From $130
4/11/24
Wedbush
Redwood Trust, Inc.
RWT
Neutral
Outperform
$6.5 Down From $8
4/11/24
Wedbush
Arbor Realty Trust Inc.
ABR
Neutral
Outperform
$13 Down From $17
4/2/24
Wedbush
Century Communities, Inc.
CCS
Underperform
Neutral
$82 Down From $92
4/2/24
Wedbush
D R Horton Inc.
DHI
Underperform
Neutral
$130
4/2/24
Wedbush
Lennar Corp.
LEN
Underperform
Neutral
$144
4/2/24
Wedbush
LGI Homes Inc
LGIH
Underperform
Neutral
$74 Down From $88
4/2/24
Wedbush
Meritage Homes Corp.
MTH
Underperform
Neutral
$148 Down From $155
3/19/24
Wedbush
Fusion Pharmaceuticals Inc.
FUSN
Neutral
Outperform
$24 Up From $13
2/20/24
Wedbush
Hudson Pacific Properties Inc.
HPP
Neutral
Outperform
$7.5 Down From $11
Buy this Content
Editors Pick
Nuvalent Stock Climbs 39% On $10.6 Bln Takeover Deal With GSK
June 09, 2026 08:05 ET
OpenAI Joins IPO Race With Confidential S-1 Filing
June 09, 2026 05:10 ET
Tate & Lyle Stock Up On $3.6 Bln Cash Deal To Be Bought By Ingredion
June 08, 2026 07:11 ET
SpaceX Aims To Raise Around $75 Bln In IPO, Musk May Become World's First Trillionaire
June 04, 2026 07:12 ET